|Articles|August 1, 2017
- BioPharm International-08-01-2017
- Volume 30
- Issue 8
BioPharm International, August 2017 Issue (PDF)
Click the title above to open the BioPharm International August 2017 issue in an interactive PDF format.
Advertisement
Articles in this issue
about 8 years ago
Gottlieb Tackles Opioids, Drug Costs, and Innovationabout 8 years ago
CDMOs: New Administration, New Frontierabout 8 years ago
Just the Biopharma Facts, Pleaseabout 8 years ago
Process Chromatography: Continuous Optimizationabout 8 years ago
Optimizing Cell-Culture Mediaabout 8 years ago
Keeping it Clean: Biopharmaceutical Cleaning Validationabout 8 years ago
The Role of Quality Standards for Biomanufacturing Raw Materialsabout 8 years ago
Avoiding Investigational Failures and Discrepanciesabout 8 years ago
Analytical Strategy in the Development of BiosimilarsNewsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Biologics, Obesity, China Top Financial Trends Reshaping Pharma R&D in J.P. Morgan Report
2
Everything to Know About Cell and Gene Therapy in 2025
3
Why Product-Specific Strategies Matter in Advanced Therapy Manufacturing (Part 3)
4
Overcoming Funding Challenges and Maintaining Optimism in CGTs (Part 1)
5
